The stronger outlook follows mixed results from other major medical device makers in the latest quarter, after both Abbott ...

Add Yahoo as a preferred source to see more of our stories on Google. Edwards Lifesciences’ transcatheter aortic valve replacement (TAVR) system has demonstrated positive results in a long-term trial ...

Edwards Lifesciences Corp (EW) reports a robust 12.7% sales growth in Q1 2026, raises full-year guidance, and showcases significant advancements in TAVR and TMTT segments.

SAN FRANCISCO--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The ...

Analysts expect Edwards to post earnings of 73 cents per share on revenue of $1.6 billion, representing year-over-year growth of 17.6% and 13.48% respectively. That would mark a sequential improvement ...

Add Yahoo as a preferred source to see more of our stories on Google. Edwards Lifesciences' Sapien 3 Ultra system. The artificial heart valve is pushed through the blood vessels via a catheter and ...

Edwards Lifesciences reported first-quarter earnings and revenue above Wall Street forecasts, driven by robust growth in heart valve therapies. The company raised its full-year 2026 sales and earnings ...

Edwards Lifesciences (NYSE:EW) reported first-quarter 2026 results that management said came in ahead of expectations, driven ...

Edwards Lifesciences (NYSE:EW) today unveiled its “Stay in the Race” initiative to support heart valve health.

Edwards Lifesciences today posted first-quarter financial results that came in ahead of the Wall Street forecast.

Edwards Lifesciences might be a pioneer in the transcatheter aortic valve replacement market, but that doesn’t mean it’s smooth sailing in the space. The Irvine, CA-based company faces stiff ...

SAPIEN 3, which showed superiority at 1 year, also demonstrates compelling outcomes equivalent to surgery at seven years SAN FRANCISCO--(BUSINESS WIRE)-- Edwards Lifesciences (EW) today announced ...